Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Cancer's hidden toll: new study tracks sexual health in patients and partners

NCT ID NCT07557342

Knowledge-focused Sponsor: Casa di Cura Dott. Pederzoli Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 200 women with gynecologic cancer and their partners to see how sexual function changes over time. Researchers use questionnaires at diagnosis, 6 months, and 12 months after treatment. The goal is to understand when sexual counseling might be most helpful, without changing standard medical care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients diagnosed with gynecological cancer will be enrolled, regardless of the type of treatment proposed (surgery, concurrent chemoradiotherapy alone, neoadjuvant chemotherapy), provided they meet the inclusion criteria, do not meet any exclusion criteria (see above), and give their informed and unconditional consent to participate in the study by signing the appropriate forms. A necessary condition is that the patient's partner also provides informed and unconditional consent to participate in the study by signing the appropriate forms and agrees to complete the questionnaires within the same timeframe as the patient.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients diagnosed with gynecological cancer: malignant ovarian tumor, ovarian tumor of uncertain behavior, cervical cancer, endometrial cancer, uterine sarcoma, vulvar cancer, vaginal cancer * Sexually active * Women who have a partner * Aged between 18 and 75 * Women of any sexual orientation * Understanding and knowledge of the Italian language * Signing of the informed consent form * Signing of the informed consent form by the partner Exclusion Criteria: * Benign gynecological conditions * Age \< 18 or \> 75 * Virgins or women who are no longer sexually active * Women with psychiatric or neurological disorders * Women or partners who have already undergone sexual counseling or sex therapy * Women who are unable to sign the informed consent form for the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

borderline epithelial tumor of ovary cervical cancer endometrial cancer female reproductive organ cancer ovarian cancer Sexuality uterine corpus sarcoma vaginal cancer vulva cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gynecologic cancers Sexual wellness

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • IEO - Istituto Europeo di Oncologia

    NOT_YET_RECRUITING

    Padova, Padova, 20141, Italy

  • IRCCS Azienda ospedaliero-universitaria di Bologna - Policlinico Sant'Orsola

    NOT_YET_RECRUITING

    Bologna, Bologna, 40138, Italy

  • IRCCS Materno infantile Burlo Garofolo

    NOT_YET_RECRUITING

    Trieste, Trieste, 34137, Italy

  • Ospedale P. Pederzoli Casa di Cura Privata S.p.A.

    RECRUITING

    Peschiera del Garda, Verona, 37019, Italy

  • Policlinico Universitario Fondazione Agostino Gemelli

    NOT_YET_RECRUITING

    Roma, Roma, 0630151, Italy

  • Presidio Ospedaliero Universitario "Santa Maria della Misericordia"

    NOT_YET_RECRUITING

    Udine, Udine, 33100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.